| Primary |
| Hiv Infection |
72.6% |
| Antiretroviral Therapy |
9.0% |
| Acquired Immunodeficiency Syndrome |
3.8% |
| Tuberculosis |
3.0% |
| Prophylaxis |
1.5% |
| Pulmonary Tuberculosis |
1.5% |
| Hepatitis C |
1.3% |
| Pneumocystis Jiroveci Pneumonia |
0.9% |
| Plasmablastic Lymphoma |
0.9% |
| Antiviral Prophylaxis |
0.7% |
| Haemophilia |
0.6% |
| Cytomegalovirus Chorioretinitis |
0.5% |
| Diarrhoea |
0.5% |
| Hiv Test Positive |
0.5% |
| Mycobacterium Avium Complex Infection |
0.5% |
| Chest Discomfort |
0.5% |
| Contraception |
0.5% |
| Depression |
0.5% |
| Hypertension |
0.4% |
| Retroviral Infection |
0.3% |
|
| Pregnancy |
29.4% |
| Vomiting |
9.2% |
| Drug Resistance |
7.0% |
| Immune Reconstitution Syndrome |
6.3% |
| Rash |
4.4% |
| Respiratory Failure |
3.8% |
| Maternal Drugs Affecting Foetus |
3.5% |
| Pancytopenia |
3.5% |
| Hepatic Cirrhosis |
3.2% |
| Hyperlactacidaemia |
3.2% |
| Renal Impairment |
3.2% |
| Anaemia |
2.8% |
| Hepatotoxicity |
2.8% |
| Pyrexia |
2.8% |
| Drug Interaction |
2.5% |
| Hypoplastic Right Heart Syndrome |
2.5% |
| Neutropenia |
2.5% |
| Pulmonary Tuberculosis |
2.5% |
| Talipes |
2.5% |
| Congenital Anomaly |
2.2% |
|
| Secondary |
| Hiv Infection |
65.9% |
| Drug Use For Unknown Indication |
7.7% |
| Antiretroviral Therapy |
4.8% |
| Drug Exposure During Pregnancy |
3.4% |
| Product Used For Unknown Indication |
3.3% |
| Tuberculosis |
2.1% |
| Acquired Immunodeficiency Syndrome |
2.1% |
| Prophylaxis |
1.4% |
| Antifungal Prophylaxis |
1.3% |
| Hiv Test Positive |
1.1% |
| Hepatitis C |
1.0% |
| Prophylaxis Against Hiv Infection |
1.0% |
| Mycobacterium Avium Complex Infection |
0.7% |
| Diarrhoea |
0.7% |
| Hypertension |
0.7% |
| Pulmonary Tuberculosis |
0.7% |
| Insomnia |
0.6% |
| Antiviral Treatment |
0.5% |
| Antibiotic Prophylaxis |
0.5% |
| Chest Discomfort |
0.5% |
|
| Vomiting |
19.9% |
| Weight Decreased |
8.8% |
| Myocardial Infarction |
6.8% |
| Immune Reconstitution Syndrome |
5.7% |
| Pyrexia |
5.1% |
| Drug Exposure During Pregnancy |
5.0% |
| Tuberculosis |
5.0% |
| Hepatitis |
4.4% |
| Stillbirth |
4.4% |
| Abortion Spontaneous |
4.1% |
| White Blood Cell Count Decreased |
3.9% |
| Portal Hypertension |
3.7% |
| Pregnancy |
3.7% |
| Lactic Acidosis |
3.5% |
| Progressive External Ophthalmoplegia |
3.3% |
| Vanishing Bile Duct Syndrome |
3.0% |
| Lymphoma |
2.6% |
| Pneumothorax |
2.4% |
| Microcephaly |
2.3% |
| Pneumonia |
2.3% |
|
| Concomitant |
| Hiv Infection |
63.7% |
| Drug Use For Unknown Indication |
6.9% |
| Tuberculosis |
4.9% |
| Product Used For Unknown Indication |
4.6% |
| Antiretroviral Therapy |
3.5% |
| Hepatitis C |
2.1% |
| Prophylaxis |
1.9% |
| Acquired Immunodeficiency Syndrome |
1.5% |
| Antibiotic Prophylaxis |
1.5% |
| Antifungal Prophylaxis |
1.1% |
| Mycobacterium Avium Complex Infection |
1.1% |
| Opportunistic Infection Prophylaxis |
1.1% |
| Oral Candidiasis |
1.1% |
| Burkitt's Lymphoma |
0.9% |
| Depression |
0.9% |
| Hiv Test Positive |
0.7% |
| Hypertension |
0.7% |
| Prophylaxis Against Hiv Infection |
0.7% |
| Pneumocystis Jiroveci Pneumonia |
0.6% |
| Cytomegalovirus Infection |
0.6% |
|
| Vomiting |
10.5% |
| Renal Failure Acute |
8.1% |
| Abortion Spontaneous |
7.8% |
| Renal Failure |
6.8% |
| Pancytopenia |
6.4% |
| Pyrexia |
5.7% |
| Arrhythmia |
5.4% |
| Rash |
4.4% |
| Uveitis |
4.4% |
| Viral Load Increased |
4.4% |
| Death |
4.1% |
| Renal Impairment |
4.1% |
| Weight Decreased |
4.1% |
| Abortion Induced |
3.7% |
| Myocardial Infarction |
3.7% |
| Rhabdomyolysis |
3.7% |
| Immune Reconstitution Syndrome |
3.4% |
| Syncope |
3.4% |
| Kaposi's Sarcoma |
3.0% |
| Renal Tubular Disorder |
3.0% |
|
| Interacting |
| Hiv Infection |
43.8% |
| Contraception |
12.5% |
| Drug Use For Unknown Indication |
7.8% |
| Antiretroviral Therapy |
7.0% |
| Hypertension |
7.0% |
| Product Used For Unknown Indication |
3.9% |
| Angina Pectoris |
2.3% |
| Lung Neoplasm Malignant |
2.3% |
| Asthma |
1.6% |
| Bipolar Disorder |
1.6% |
| Chronic Myeloid Leukaemia |
1.6% |
| Histoplasmosis |
1.6% |
| Histoplasmosis Disseminated |
1.6% |
| Thrombophlebitis |
1.6% |
| Attention Deficit/hyperactivity Disorder |
0.8% |
| Bipolar I Disorder |
0.8% |
| Haemorrhoids |
0.8% |
| Mycosis Fungoides |
0.8% |
| Tuberculosis |
0.8% |
|
| Drug Interaction |
14.3% |
| Hypotension |
10.7% |
| Osteomalacia |
7.1% |
| Tachypnoea |
7.1% |
| Virologic Failure |
7.1% |
| Drug Level Decreased |
3.6% |
| Ectopic Pregnancy |
3.6% |
| Hepatic Enzyme Increased |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Meningeal Disorder |
3.6% |
| Platelet Count Decreased |
3.6% |
| Renal Impairment |
3.6% |
| Rhabdomyolysis |
3.6% |
| Ruptured Ectopic Pregnancy |
3.6% |
| Self-medication |
3.6% |
| Suicide Attempt |
3.6% |
| Thrombocytopenia |
3.6% |
| Tuberculosis |
3.6% |
| Unintended Pregnancy |
3.6% |
| Viral Load Increased |
3.6% |
|
